Socioeconomic disparities and breast cancer hormone receptor status

Cancer Causes and Control

Volumn 23, Issue 6, 2012, Pages 951-958

  Andaya, Abegail A ^a   Enewold, Lindsey ^a   Horner, Marie Josèphe ^b   Jatoi, Ismail ^c   Shriver, Craig D ^a,d,e   Zhu, Kangmin ^a  

^a US Military Cancer Institute   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Breast cancer; Estrogen receptor; Hormone receptor; Poverty; Progesterone receptor; Socioeconomic status

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; ARTICLE; ASIAN; BREAST CANCER; CANCER STAGING; CAUCASIAN; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PACIFIC ISLANDER; POVERTY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SOCIAL STATUS;

BREAST NEOPLASMS; ETHNIC GROUPS; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; REGISTRIES; RISK FACTORS; SEER PROGRAM; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84862500152     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9966-1     Document Type: Article

References (40)

1. Osborne CK, Yochmowitz MG, Knight WA 3rd, McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46(12 Suppl):2884-2888 (Pubitemid 11205652)
2. Rastelli F, Crispino S (2008) Factors predictive of response to hormone therapy in breast cancer. Tumori 94(3):370-383
3. Early Breast Cancer Trialists' Collaborative Group (2001) Tamoxifen for early breast cancer. Cochrane Database Syst Rev 1:CD000486
4. Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK et al (2005) Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 97(17):1254-1261 (Pubitemid 41535366)
5. Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6
6. Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW (2001) Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92(1):37-45 (Pubitemid 32623038)
7. Stanford JL, Greenberg RS (1989) Breast cancer incidence in young women by estrogen receptor status and race. Am J Public Health 79(1):71-73 (Pubitemid 19028150)
8. Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D et al (1994) Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3(2):127-135 (Pubitemid 24170054)
9. Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22(1):55-65
10. Gordon NH (1995) Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142(8):796-803
11. Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control 19(10):1305-1318
12. Data: Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat database: incidence - SEER 17 regs research data + Hurricane Katrina impacted Louisiana cases, Nov 2009 Sub (1973-2007 varying) - Linked to county attributes - total U.S., 1969-2007 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission
13. Surveillance epidemiology and end results. Race recode changes. http://seer.cancer.gov/seerstat/variables/seer/race-ethnicity. Accessed 1 Aug 2011
14. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2009) American joint committee on cancer staging manual, 7th edn. Springer, New York, NY
15. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The public health disparities geocoding project. Am J Epidemiol 156(5):471-482 (Pubitemid 34976986)
16. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV (2003) Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures - the public health disparities geocoding project. Am J Public Health 93(10):1655-1671 (Pubitemid 38477631)
17. Singh GK, Miller BA, Hankey BF, Edwards BK (2003) Area socioeconomic variations in U.S. Cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI cancer surveillance monograph series, number 4. National Cancer Institute, Bethesda, MD, NIHPublication No 03-0000.
18. Hill K (1996) The demography of menopause. Maturitas 23(2): 113-127
19. Morabia A, Flandre P (1992) Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol 21(2):222-228
20. Spiegelman D, Hertzmark E (2005) Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162(3):199-200 (Pubitemid 41373523)
21. Thomson CS, Hole DJ, Twelves CJ, Brewster DH, Black RJ (2001) Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health 55(5):308-315 (Pubitemid 32336969)
22. Vona-Davis L, Rose DP (2009) The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health Larchmt 18(6):883-893
23. Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 12(10):1053-1060 (Pubitemid 37310262)
24. Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L (2001) Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91(4):580-584 (Pubitemid 32115117)
25. Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD (1989) Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer 59(1):119-125 (Pubitemid 19051323)
26. Enger SM, Ross RK, Paganini-Hill A, Longnecker MP, Bernstein L (1999) Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer 79(7-8):1308-1314 (Pubitemid 29087916)
27. Dallal CM, Sullivan-Halley J, Ross RK, Wang Y, Deapen D, Horn-Ross PL et al (2007) Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med 167(4):408-415 (Pubitemid 46333943)
28. Peters TM, Schatzkin A, Gierach GL, Moore SC, Lacey JV Jr, Wareham NJ et al (2009) Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 18(1):289-296
29. Park Y, Brinton LA, Subar AF, Hollenbeck A, Schatzkin A (2009) Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr 90(3):664-671
30. Champagne CM, Bogle ML, McGee BB, Yadrick K, Allen HR, Kramer TR et al (2004) Dietary intake in the lower Mississippi delta region: results from the Foods of our Delta Study. J Am Diet Assoc 104(2):199-207 (Pubitemid 38183186)
31. Turrell G, Hewitt B, Patterson C, Oldenburg B, Gould T (2002) Socioeconomic differences in food purchasing behaviour and suggested implications for diet-related health promotion. J Hum Nutr Diet 15(5):355-364 (Pubitemid 35153667)
32. Bennett GG, McNeill LH, Wolin KY, Duncan DT, Puleo E, Emmons KM (2007) Safe to walk? Neighborhood safety and physical activity among public housing residents. PLoS Med 4(10):1599-1606; discussion 1607
33. Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25(13):1683-1690 (Pubitemid 46797948)
34. Narod SA, Dube MP (2001) Re: biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 93(2):151-152 (Pubitemid 32111993)
35. Anderson WF, Jatoi I, Devesa SS (2006) Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat 99(3):333-340 (Pubitemid 44337926)
36. Porta M, Bosch de Basea M, Benavides FG, Lopez T, Fernandez E, Marco E et al (2008) Differences in serum concentrations of organochlorine compounds by occupational social class in pancreatic cancer. Environ Res 108(3):370-379
37. Sexton K, Adgate JL, Fredrickson AL, Ryan AD, Needham LL, Ashley DL (2006) Using biologic markers in blood to assess exposure to multiple environmental chemicals for inner-city children 3-6 years of age. Environ Health Perspect 114(3):453-459 (Pubitemid 43338273)
38. Hoyer AP, Jorgensen T, Rank F, Grandjean P (2001) Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer 1:8
39. Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE et al (2001) Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 12(5):395-404 (Pubitemid 32735132)
40. Haggstrom DA, Quale C, Smith-Bindman R (2005) Differences in the quality of breast cancer care among vulnerable populations. Cancer 104(11):2347-2358 (Pubitemid 41691555)